article Open AccessTop 1% cited
The global burden of melanoma: results from the Global Burden of Disease Study 2015
British Journal of Dermatology · 2017 · Vol. 177(1) · pp. 134–140
Chanté Karimkhani✉(University of Colorado Denver)A. C. Green(QIMR Berghofer Medical Research Institute)Tamar Nijsten(Erasmus MC)Martin A. Weinstock(Brown University)Robert P. Dellavalle(United States Department of Veterans Affairs)Mohsen Naghavi(Institute for Health Metrics and Evaluation)Christina Fitzmaurice(University of Washington)
Abstract
The greatest burden from melanoma falls on Australasian, North American, European, elderly and male populations, which is consistent with previous investigations. These substantial disparities in melanoma burden worldwide highlight the need for aggressive prevention efforts. The Global Burden of Disease Study results can help shape melanoma research and public policy.
Cutaneous Melanoma Detection and ManagementSkin Protection and AgingHealth Systems, Economic Evaluations, Quality of LifeLife expectancyYears of potential life lostMedicineBurden of diseaseDemographyDisease burdenIncidence (geometry)EpidemiologyDisability-adjusted life yearPublic health
MeSH terms
Global Burden of DiseaseAdolescentAdultAgedAged, 80 and overFemaleHumansMaleMelanomaResidence CharacteristicsSkin NeoplasmsGlobal HealthIncidenceCost of IllnessAge Distribution
Funding
- Bill and Melinda Gates Foundation
Citations
434
FWCI
21.31
field-weighted impact
References
29
Percentile
100%
vs. same field & year
Citations per year
References
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
The Lancet · 2016 · 7,320 citations
Related articles
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.